跳至主要内容
临床试验/NCT01222156
NCT01222156Unknown1 期

Remote Intracardiac Catheter Target Acquisition Using the Magnetecs Catheter Guidance Control and Imaging (CGCI) System

Magnetecs Corporation2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
1 期
入组人数
20
试验地点
2
主要终点
Intracardiac anatomic site target acquisition and repetition acquisition success rates

研究概览

简要总结

The Magnetecs Catheter Guidance Control and Imaging (CGCI) system is a magnetic remote navigation system which is comprised of a magnetic chamber of eight electromagnets around the patient torso. The system can change the magnetic field almost instantaneously and enables almost real time manipulation of a special magnetic catheter (Maxwell mapping catheter) which results in accurate, repeatable, rapid and safe target acquisition within the four chambers of the human heart.

The trial is a prospective, non-randomized, clinical one designed to test the study hypotheses of (a) technical equivalence of the study device in comparison to other magnetic remote navigation systems, (b) performance equivalence or non-inferiority of the study device target acquisition capability compared to presently used catheter navigation techniques, and (c) safety equivalence or non-inferiority of the study device in comparison to catheter navigation devices using other navigation techniques.

详细描述

The CGCI system is comprised of (a) magnetic chamber of eight electromagnets around the patient torso, (b) the Maxwell ©, a 7Fr. Inquiry™ catheter with an attached magnetic pellet manufactured by St. Jude Medical, Inc. The Maxwell © is equivalent to a 7 Fr. Inquiry™ cleared under 510(K) K022380, and (c) a Agilis ES Active Sheath© which is a modified 7.5 Fr. Steerable Introducer is equivalent to the Agilis NxT™ Steerable Introducer, manufactured by St. Jude Medical, Inc. and cleared under 510(K) K061363.

Study Rationale: Current manual manipulations of mapping catheters are imprecise and difficult to control. The Magnetecs CGCI system enables almost real time manipulation of the Maxwell mapping catheter which results in accurate, repeatable, rapid and safe target acquisition. The CGCI System is intended to navigate a magnetic catheter within the four chambers of the human heart by orienting and moving the catheter tip to designated anatomically significant targets.

Design: A prospective, non-randomized, clinical trial designed to test the study hypotheses of (a) technical equivalence of the study device in comparison to other magnetic remote navigation systems, (b) performance equivalence or non-inferiority of the study device target acquisition capability compared to presently used catheter navigation techniques, and (c) safety equivalence or non-inferiority of the study device in comparison to catheter navigation devices using other navigation techniques.

Target Population:Patients who have recurrent cardiac rhythm disturbances and who meet clinically recognized indications for performance of an intracardiac mapping procedure.

Planned Number of Subjects: A total of 40 patients

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are clinically eligible for catheter based therapy of cardiac arrhythmias
  • Body Mass Index (BMI) < 40
  • Signed Informed Consent

排除标准

  • Indication for atrial fibrillation ablation
  • Indication for ischemic ventricular tachycardia ablation
  • Severe cerebrovascular disease
  • Serum creatinine >2.5
  • Active gastrointestinal bleeding
  • Active infection or fever
  • Short life expectancy (<6 months)
  • Severe uncontrolled systemic hypertension
  • Severe electrolyte imbalance
  • Congestive heart failure (NYHA Class IV)
  • Unstable angina
  • Recent MI (<4 weeks)
  • Bleeding or clotting disorders
  • Uncontrolled diabetes
  • Inability to receive IV Anticoagulants
  • Presence of intracardiac thrombus
  • Patients with prosthetic cardiac valves
  • Patients with permanent pacemakers or ICD's
  • Enrollment in any other ongoing clinical trial

结局指标

主要结局

Intracardiac anatomic site target acquisition and repetition acquisition success rates

时间窗: within 1 minute

Intracardiac anatomic site target acquisition and repetition acquisition success rates of a mapping catheter remotely navigated by the Magnetecs CGCI system

Serious adverse event rate

时间窗: within 7 days

Serious adverse event rate at intracardiac anatomic site target acquisition of a mapping catheter remotely navigated by the Magnetecs CGCI system

次要结局

  • Intracardiac anatomic site target acquisition and repetition acquisition duration(within 1 minute)
  • Pacing stimulation thresholds levels at the target intracardiac anatomic sites remotely and manually acquired(within 10 minutes)
  • Electrogram frequency spectrum and signal/noise levels at the target intracardiac anatomic sites remotely and manually acquired by the Magnetecs CGCI system and a conventional catheter manually operated respectively.(within 1 minute)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验